BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10467532)

  • 1. [Effectiveness and safety of hydroxyethyl-rutosides in the local treatment of symptoms of venous insufficiency during air travel].
    Gouny AM; Horovitz D; Gouny P; Sauvage E; Nussaume O
    J Mal Vasc; 1999 Jun; 24(3):214-20. PubMed ID: 10467532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
    Rehn D; Golden G; Nocker W; Diebschlag W; Lehmacher W
    Arzneimittelforschung; 1993 Oct; 43(10):1060-3. PubMed ID: 8267669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
    Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T
    Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
    Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
    Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency.
    Poynard T; Valterio C
    Vasa; 1994; 23(3):244-50. PubMed ID: 7975870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
    Unkauf M; Rehn D; Klinger J; de la Motte S; Grossmann K
    Arzneimittelforschung; 1996 May; 46(5):478-82. PubMed ID: 8737630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double blind trial of oral O. B-hydroxyethyl rutosides for stasis leg ulcers.
    Mann RJ
    Br J Clin Pract; 1981 Feb; 35(2):79-81. PubMed ID: 7020736
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
    Pedersen FM; Hamberg O; Sørensen MD; Neland K
    Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of edema and flight microangiopathy with Venoruton (HR), (0-[beta-hydroxyethyl]-rutosides) in patients with varicose veins.
    Cesarone MR; Belcaro G; Ricci A; Brandolini R; Pellegrini L; Dugall M; Di Renzo A; Vinciguerra G; Gizzi G; Cornelli U; Errichi BM; Corsi M; Ippolito E; Adovasio R; Cacchio M; Stuard S; Larnier C; Candiani C; Cerritelli F
    Angiology; 2005; 56(3):289-93. PubMed ID: 15889196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LONFLIT4-Venoruton Study: a randomized trial--prophylaxis of flight-edema in venous patients.
    Cesarone MR; Belcaro G; Brandolini R; Di Renzo A; Bavera P; Dugall M; Simeone E; Acerbi G; Ippolito E; Winford M; Candiani C; Golden G; Ricci A; Stuard S
    Angiology; 2003; 54(2):137-42. PubMed ID: 12678187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers].
    Stegmann W; Hubner K; Deichmann B; Muller B
    Phlebologie; 1987; 40(1):149-56. PubMed ID: 3554278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
    Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M
    Angiology; 2005; 56(1):1-8. PubMed ID: 15678250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of hydroxyethylrutosides on capillary filtration in moderate venous hypertension: a double blind study.
    Renton S; Leon M; Belcaro G; Nicolaides AN
    Int Angiol; 1994 Sep; 13(3):259-62. PubMed ID: 7822903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flight microangiopathy in medium-to-long distance flights: prevention of edema and microcirculation alterations with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective, randomized, controlled trial.
    Cesarone MR; Belcaro G; Incandela L; Geroulakos G; Griffin M; Lennox A; DeSanctis MT; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S17-20. PubMed ID: 12011968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.
    Cesarone MR; Incandela L; DeSanctis MT; Belcaro G; Griffin M; Ippolito E; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S21-4. PubMed ID: 12011969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency.
    Vanscheidt W; Jost V; Wolna P; Lücker PW; Müller A; Theurer C; Patz B; Grützner KI
    Arzneimittelforschung; 2002; 52(4):243-50. PubMed ID: 12040966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
    Beltramino R; Penenory A; Buceta AM
    Int Angiol; 1999 Dec; 18(4):337-42. PubMed ID: 10811525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-(beta-hydroxyethyl)-rutosides (Paroven; Venoruton): new studies, improved safety, and novel cardiovascular applications.
    Cesarone MR; Belcaro G; Grossi MG
    Angiology; 2008; 59 Suppl 1():5S-6S. PubMed ID: 18287161
    [No Abstract]   [Full Text] [Related]  

  • 20. Time course of the anti-oedematous effect of different dose regimens of O-(beta-hydroxyethyl) rutosides in healthy volunteers.
    Rehn D; Nocker W; Diebschlag W; Golden G
    Arzneimittelforschung; 1993 Mar; 43(3):335-8. PubMed ID: 8489563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.